Deal Flow
Letter · prints on one page
Transaction tear sheetData as of Nov 7, 2026
M&A · Healthcare · Buyer's industry: Pharmaceutical Preparations

Aditxt, Inc. to acquire Proprietary Adductomics

Announced Mar 28, 2025 · Closed Mar 28, 2025 · Private target

Deal value$1M
Premium—To unaffected price
EV / Adj. EBITDA—
ConsiderationNot disclosed

Transaction

Acquirer
Aditxt, Inc. (ADTX)
Target
Proprietary Adductomics
Buyer type
Strategic
Offer price per share
—
Enterprise value
—
Status
Closed Mar 28, 2025

Deal protections

Not disclosed for private-company acquisitions.

Advisors

To the acquirer
Not disclosed
To the target
Not disclosed

Classification

Sector
Healthcare
Buyer's industry
Pharmaceutical Preparations
Sources
  • 8-K (EX-99.1) · Mar 28, 2025

Prepared with Castle from public SEC EDGAR filings. Figures are extracted automatically; verify against the source documents. Not investment advice.